Download program This program will cover the latest advancements in the research field of the two genetically related bacterial pathogens such as Neisseria meningitidis, which causes a devasting diseases such as meningitis and sepsis or and Neisseria gonorrhoeae, a WHO priority pathogen resistant t

Funding for researchers from Gavi-eligible countries IPNC organizers and the Sclavo Vaccine Association ETS are pleased to offer a number of Travel Grants for researchers from Gavi-eligible countries selected by the Scientific Committee to present at the IPNC2025 Conference. Presenters who qualify

Abstracts can be submitted via the online Abstract Submission Service only, please don’t send abstract by email Abstract must be in English The deadline for abstract submission is now postponed to 30 November 2024 at 23:59:59 Central European Time. A Late-Breaking Abstract submission only for

Carolyne Deal, National Institute of Allergy and Infectious Diseases, Bethesda, USA Sinead Delany-Moretlwe, Wits RHI, University of the Witwatersrand, Johannesburg, South Africa Joseph A. Duncan, University of North Carolina School of Medicine, Chapell Hill, USA Ann Jerse, Uniformed Services Univ

Abdullah M Assiri - Public Health Directorate, Ministry of Health, Saudi Arabia Mathieu Coureuil - Institut-Necker-Enfants-Malades (INSERM), Paris, France Carolyn Deal - National Institute of Allergy and Infectious Diseases, Bethesda, USA Peter Dull - Bill & Melinda Gates Foundation, Seattle, USA

1. Neisseria: Clinical relevance and epidemiology in 2025 Includes studies in epidemiology of meningitis and gonorrhea worldwide, with particular focus on developing countries, evaluation and definition of clinical disease, epidemiology across all ages including adults, and strategies for prevention